Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
- 4 April 2008
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 371 (9618), 1085-1097
- https://doi.org/10.1016/s0140-6736(08)60486-9
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Olanzapine and haloperidol in first episode psychosis: Two-year dataSchizophrenia Research, 2006
- Linking the PANSS, BPRS, and CGI: Clinical ImplicationsNeuropsychopharmacology, 2006
- Clinical trials for antipsychotic drugs: design conventions, dilemmas and innovationsNature Reviews Drug Discovery, 2006
- The European First Episode Schizophrenia Trial (EUFEST): Rationale and design of the trialSchizophrenia Research, 2005
- Risperidone and Haloperidol in First-Episode Psychosis: A Long-Term Randomized TrialAmerican Journal of Psychiatry, 2005
- Comparative Efficacy and Safety of Atypical and Conventional Antipsychotic Drugs in First-Episode Psychosis: A Randomized, Double-Blind Trial of Olanzapine Versus HaloperidolAmerican Journal of Psychiatry, 2003
- Relationship Between Dopamine D2 Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode SchizophreniaAmerican Journal of Psychiatry, 2000
- Multilevel time series models with applications to repeated measures dataStatistics in Medicine, 1994
- The St. Hans Rating Scale for extrapyramidal syndromes: reliability and validityActa Psychiatrica Scandinavica, 1993
- The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patientsActa Psychiatrica Scandinavica, 1987